Medicine details
Image | |
Name | Remaprost |
Dosage | Eye Drops |
Generic Name | Latanoprost |
Classes |
Dermatological/Topical Agent Ophthalmic Preparation Glaucoma Agent |
Diseases |
Glaucoma Ophthalmic Disease |
Company | Reman Drug Laboratories Ltd. |
Drug Package Details
Strength | 5 mg/100 ml |
Storage Condition | |
Origin Country | Bangladesh |
Commercial Pack | 1 |
Price per pack | ৳ 496.87 |
Cost per pack | ৳ 437.25 |
Package unit | 2.5 ml drops |
Price per unit | ৳ 496.87 |
Cost per unit | ৳ 437.25 |
Discount | 0 |
Coupon | |
Remarks |
Latanoprost
Latanoprost is a prostaglandin analogue. It is a selective FP prostanoid receptor agonist which is believed to reduce intraocular pressure by increasing uveoscleral outflow.
Latanoprost is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
- Open angle glaucoma
- Ocular hypertension
- Recommended therapy is one eye drop in the affected eye(s) once daily. Optimal effect is obtained if Latanoprost eye drops is administered in the evening.
- The dosage of Latanoprost eye drops should not exceed once daily since it has been shown that more frequent administration decreases the intraocular pressure lowering effect.
- If one dose is missed, treatment should continue with the next dose as normal
Latanoprost may cause the following side effects-
- ocular hyperemia
- decreased visual acuity
- eye discomfort
- foreign body sensation
- pain
- pruritus
- abnormal vision
- blepharitis
- blurred vision
- cataract
- conjunctivitis
- corneal staining
- dry eye
- iris discoloration
- keratitis
- lid margin crusting
- ocular inflammation
- photophobia
- subconjunctival hemorrhage and tearing
- Pigmentation: Pigmentation of the iris, periorbital tissue (eyelid) and eyelashes can occur. Iris pigmentation likely to be permanent.
- Eyelash Changes: Gradual change to eyelashes including increased length, thickness and number of lashes. It is usually reversible.
- Latanoprost should be used with caution in patients with active intraocular inflammation (e.g., uveitis) because the inflammation may be exacerbated.
- Macular edema, including cystoid macular edema, has been reported during treatment with Latanoprost ophthalmic
- Latanoprost has not been evaluated for the treatment of angle-closure, inflammatory or neovascular glaucoma.
- Contact lenses should be removed prior to instillation of Latanoprost and may be reinserted 15 minutes following its administration.
- Bacterial keratitis has been linked to the use of multiple-dose containers of topical ophthalmic products. These containers had been contaminated inadvertently by patients, the majority of whom had a concurrent corneal disease or a disruption of the ocular epithelial surface.
Contraindication
None known.
None known.
None known.